Results 201 to 210 of about 34,040 (268)

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy. [PDF]

open access: yesWorld J Surg Oncol
Muslumanoglu M   +16 more
europepmc   +1 more source

Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes. [PDF]

open access: yesCancers (Basel)
Cebrecos I   +14 more
europepmc   +1 more source

Trends in Axillary Lymph Node Dissection After Mastectomy Among Patients With Limited Nodal Burden.

open access: yesJAMA Netw Open
Wang T   +11 more
europepmc   +1 more source

Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol. [PDF]

open access: yesBreast
van Hemert AKE   +10 more
europepmc   +1 more source

Role of Absorbable Polysaccharide Hemostatic Powder in the Prevention of Complications After Axillary Lymph Node Dissection in Breast Cancer Patients: A Multicenter Retrospective Analysis. [PDF]

open access: yesMedicina (Kaunas)
Parisi S   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy